The Recall Desk
SevereFDA (Devices)·Z-1488-2023·Announced 2023-05-17

FDA Class I Guidewire System Recalled for Device Separation Risk

Cordis US Corp is recalling the ANGIOGUARD RX / XP Emboli Capture Guidewire System because the device may separate during procedures, risking stroke or requiring emergency intervention.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: FDA Class I classification reflects serious potential hazard. Although no illnesses or injuries have been reported to date, the potential for device separation during critical cardiovascular procedures poses significant risk of stroke or emergency intervention.

Plain-English summary

The FDA has issued a Class I recall of the ANGIOGUARD RX / XP Emboli Capture Guidewire System (Model REF 603014MC), manufactured by Cordis US Corp. The recall addresses a potential hazard in which the delivery system and capture sheath may separate during clinical use.

The separation risk is heightened during situations involving intra-procedural delays, unplanned surgical or percutaneous interventions, or when stroke complications occur. The separation is particularly problematic when it occurs while a replacement device is being prepared, as it may delay or complicate patient care.

Approximately 43 units were distributed worldwide with lot number 35265492. Healthcare providers should contact Cordis US Corp for guidance regarding affected devices and replacement options.

The recalled product

Product
ANGIOGUARD RX / XP Emboli Capture Guidewire System, REF 603014MC
Manufacturer
Cordis US Corp
Hazard
  • device-separation
  • stroke-risk

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • UDI/DI 20705032056790
  • Lot Numbers: 35265492

Distribution

Distribution scope not specified by the agency.